Retraction Note: Increased Aβ42-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer’s disease pathogenesis
Alzheimer's Research & Therapy volume 14, Article number: 76 (2022)
Retraction Note: Alz Res Ther 9, 54 (2017)
The Editors-in-Chief have retracted this article. Following publication, concerns have been raised regarding the western blot images presented in Figs. 1, 5 and 6. The authors have provided the raw data, which have been assessed by independent experts and deemed insufficient to address the concerns. The Editors-in-Chief therefore no longer have confidence in the integrity of the data in this article.
Authors Isabelle Guignot, Eva Bouguen, Karine Deschet, Maria Pueyo and Pierre-Jean Ousset agree to this retraction. Author Bruno Vellas agrees to this retraction but disagrees with the Retraction Note. Authors Hoau-Yan Wang, Caryn Trocmé-Thibierge, Elisabeth Mocaer and Vera Kiyasova do not agree to this retraction. Authors Andres Stucky, Sanket M. Shah, Jessica Kvasic and Amber Khan have not responded to any correspondence from the editor or publisher about this retraction. Author Philippe Morain is deceased.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wang, HY., Trocmé-Thibierge, C., Stucky, A. et al. Retraction Note: Increased Aβ42-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer’s disease pathogenesis. Alz Res Therapy 14, 76 (2022). https://doi.org/10.1186/s13195-022-01024-5